Selective loss of beta cell response to glucose in chronic pancreatitis.
D000284:Administration, Oral; D000941:Antigens; D001120:Arginine / Q000494:pharmacology; D002766:Cholecystokinin / Q000494:pharmacology; D002908:Chronic Disease; D005934:Glucagon / Q000494:pharmacology; D005947:Glucose / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D010195:Pancreatitis / Q000378:metabolism*; D012633:Secretin / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors; D014044:Tolbutamide / Q000494:pharmacology
D000941:Antigens; D007328:Insulin; D012633:Secretin; D005934:Glucagon; D002766:Cholecystokinin; D001120:Arginine; D014044:Tolbutamide; D005947:Glucose